Načítá se...
Targeted drug delivery using iRGD peptide for solid cancer treatment
Many solid tumor types, such as pancreatic cancer, have a generally poor prognosis, in part because the delivery of therapeutic regimen is prohibited by pathological abnormalities that block access to tumor vasculature, leading to poor bioavailability. Recent development of tumor penetrating iRGD pe...
Uloženo v:
| Vydáno v: | Mol Syst Des Eng |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258069/ https://ncbi.nlm.nih.gov/pubmed/30498580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C7ME00050B |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|